Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Epilepsy Currents|November 18, 2024
The Multidisciplinary Team in the Treatment of Patients With EpilepsyJohn Stern, Susan Stanton, Laura Howe-Martin, et al.
Epilepsy Research|February 19, 2021
Clinical pharmacokinetic and pharmacodynamic profile of midazolam nasal sprayM René Bouw, Steve S Chung, Barry Gidal, et al.
Epilepsia|October 17, 2023
Patterns of antiseizure medication utilization in the Human Epilepsy ProjectJonah Fox, Sarah Barnard, Shruti H Agashe, et al.
Epilepsy Currents|September 23, 2024
Pre- and Post-Exposure Prophylaxis for HIV in Patients Taking Anti-Seizure MedicationsWesley T Kerr, Barry Gidal, Sean N Avedissian, et al.
Epilepsia|February 20, 2025
Focal to bilateral tonic-clonic seizures in newly diagnosed focal epilepsyShruti Agashe, Gregory D Cascino, Orrin Devinsky, et al.
Epilepsia|July 14, 2022
Considerations for determining the efficacy of new antiseizure medications in children age 1 month to younger than 2 yearsJacqueline A French, Elena Cleary, Dennis Dlugos, et al.
Epilepsy Currents|September 27, 2018
Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyAndres M Kanner, Eric Ashman, David Gloss, et al.
Neurology|June 15, 2018
Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyAndres M Kanner, Eric Ashman, David Gloss, et al.
Neurology|June 15, 2018
Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyAndres M Kanner, Eric Ashman, David Gloss, et al.
Epilepsy Currents|September 27, 2018
Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyAndres M Kanner, Eric Ashman, David Gloss, et al.
Pageof 5